Public Company News

PRGO Deadline: PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit

NEW YORK, Jan. 12, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the "Class Period"), of the important January 16, 2026 lead...

2026-01-13 06:40 1489

Datasea Announces Major Acoustic Technology Advancements in Brain-Computer Interface Applications

Acoustic-Driven Technologies Poised to Support Embodied Intelligence and Health Robotics Applications in a Multi-Billion-Dollar Brain–Computer Interface Market BEIJING, Jan. 12, 2026 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a technology company specializing in aco...

2026-01-12 22:30 1840

PlayNitride and Brillink Announce Strategic Collaboration to Advance Array-Based Photonic Interconnects

HSINCHU and MIAOLI, Jan. 12, 2026 /PRNewswire/ -- PlayNitride, a global leader in MicroLED technologies, today announced a strategic collaboration with Brillink to develop a next-generation array-based photonic interconnect solution designed to deliver longer reach, lower power consumption, and ...

2026-01-12 22:00 263

Insilico Medicine Completes First Patient First Dose in BETHESDA: A Phase II Trial for Garutadustat (ISM5411), the Gut-restricted AI-driven PHD Inhibitor for the Treatment of Inflammatory Bowel Disease

CAMBRIDGE, Mass., Jan. 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage, generative AI-driven drug discovery company, today announced the completion of first patient first dose in BETHESDA: a Phase IIa clinical trial of ISM5411 (NCT07265570

2026-01-12 21:30 1523

WuXi Biologics Launches Industry-Leading Digital Twin Platform PatroLab™ Designed to Transform Bioprocessing and Manufacturing

SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of PatroLabTM, a state-of-the-art digital twin platform designed to transform bioprocess development and manufactur...

2026-01-12 21:09 4258

CARsgen and Dispatch Bio Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors

SHANGHAI, PHILADELPHIA and SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, and Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveragin...

2026-01-12 21:05 2964

ECARX Holdings Inc. Announces US$45.6 million Strategic Investment from Geely Holding Group

LONDON, Jan. 12, 2026 /PRNewswire/ -- ECARX Holdings Inc. (Nasdaq: ECX) ("ECARX" or the "Company"), a global mobility tech provider, today announced that it has entered into a subscription agreement with Geely Investment Holding Ltd. ("Geely Holding") onJanuary 8th, 2026. Under the terms of the a...

2026-01-12 20:04 4330

Haisco Grants Global Rights of Innovative Drug HSK39004 to AirNexis in Deal Exceeding USD 1 Billion

HSK39004, a novel dual‑target therapy, aims to compete in the global COPD market, highlighting innovation and international capabilities BEIJING, Jan. 12, 2026 /PRNewswire/ -- On January 9, 2026, Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an ex...

2026-01-12 20:00 1842

Equity Acquisition of Nanyue Diankong (Hengyang) Industrial Technology

SINGAPORE, Jan. 12, 2026 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD)("China Yuchai" or the "Company"), one of the largest powertrain solution manufacturers through its main operating subsidiary inChina, Guangxi Yuchai Machinery Company Limited ("Yuchai"), wishes to announce tha...

2026-01-12 19:00 5499

TAL Education Group to Announce Third Quarter of Fiscal Year 2026 Financial Results on January 29, 2026

BEIJING, Jan. 12, 2026 /PRNewswire/ -- TAL Education Group ("TAL" or the "Company") (NYSE: TAL), a smart learning solutions provider inChina, today announced that it will release its unaudited financial results for the third quarter of fiscal year 2026 endedNovember 30, 2025,  before the market o...

2026-01-12 17:30 284

WuXi AppTec Issues Positive Profit Alert for the Full Year of 2025

SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- WuXi AppTec (stock code: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today issued a Positive Profit Alert for the full year of 2025, disclosing forecasts of key operational data...

2026-01-12 17:30 1394

XPENG Charts New Course in 2026: Flagship Launch, Sales Momentum, and AI Breakthrough Propel Global Technology Ambitions

GUANGZHOU, China, Jan. 12, 2026 /PRNewswire/ -- XPENG is ushering in 2026 with transformative momentum, reinforcing its strategic evolution into an AI-driven global technology leader. The company unveiled its next-generation flagship model, celebrated a critical production milestone, and introduc...

2026-01-12 16:14 2395

Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery

TAIPEI, Jan. 12, 2026 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Samil Pharmaceuticals, Co., Ltd ("Samil", 000520.KS), for exclusive rights to the commercialization of clobetasol...

2026-01-12 16:00 2004

Tuya Smart Launches Aura, an AI Companion Robot Designed for Pets

LAS VEGAS, Jan. 12, 2026 /PRNewswire/ -- Tuya Smart (NYSE: TUYA, HKEX: 2391), a global AI cloud platform service provider, officially unveiled Aura, its first AI-powered pet companion robot, at CES 2026, the world's largest consumer electronics show.

2026-01-12 13:25 2039

Clover Initiates Phase 2 Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates

-- Phase 2 Initiation Strengthens Global First-in-Class Potential for Clover's Protein-Based RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates -- SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd.  (Clover; HKEX: 02197), a global ...

2026-01-12 12:33 190

Zylox-Tonbridge Hosts Investor Open Day, Showcasing Innovation Pipeline and Global Growth Strategy

HANGZHOU, China, Jan. 11, 2026 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190), a leading innovator in neurovascular and peripheral vascular interventional solutions, hosted its Investor Open Day at its Zhuhai Innovation Center, welcoming nearly 150 institutional investo...

2026-01-12 12:16 2787

CES 2026 | Led by a 100 TOPS High-Performance AI Module, MeiG Smart's Full-Stack AI Solutions Define the Intelligent Future

Key Highlights: * SNM983 Series: A high-performance AI module delivering up to 100 TOPS, representing an architectural revolution for theAI-native era. * MT200 Series: An industrial-grade Edge AI BOX solution that defines a new paradigm offlexible, reliable, and plug-and-play computing power....

2026-01-10 09:19 570

Autozi Internet Technology (Global) Ltd. Received Two Notification Letters from Nasdaq

BEIJING, Jan. 9, 2026 /PRNewswire/ -- Autozi Internet Technology (Global) Ltd. ("Autozi" or the "Company") (Nasdaq: AZI), one ofChina's leading and fastest-growing lifecycle automotive service and supply-chain technology platforms, announced today that it received two notification letters from Th...

2026-01-10 05:05 2365

NAMI INSIGHT One Debuts at CES 2026, Positioning Namibox at the Forefront of the AI Learning Wearables Market

SHANGHAI, Jan. 9, 2026 /PRNewswire/ -- At the 2026 International Consumer Electronics Show (CES),Namibox (Nasdaq: NAMI), the education technology brand of Jinxin Technology Holding Company, formally introducedNAMI INSIGHT One, the world's first AI learning glasses purpose-built for education-cent...

2026-01-09 22:00 487

Paranovus Entertainment Technology Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

NEW YORK, Jan. 9, 2026 /PRNewswire/ -- Paranovus Entertainment Technology Limited (NASDAQ: PAVS) today announced that onJanuary 6, 2026, it received notification from the Nasdaq Office of General Counsel stating that the Company had regained compliance with the bid price requirement as set forth ...

2026-01-09 21:45 1666
1 ... 13141516171819 ... 774